Literature DB >> 10336623

Glyceraldehyde-3-phosphate dehydrogenase from Ehrlich ascites carcinoma cells its possible role in the high glycolysis of malignant cells.

S Bagui1, M Ray, S Ray.   

Abstract

Glyceraldehyde-3-phosphate dehydrogenase has been purified to apparent homogeneity from Ehrlich ascites carcinoma (EAC) cells. The enzyme is quite active over a pH range of 7.5-9.0 with an optimum pH of 8.4-8.7. The specific activity of the enzyme is much higher than that from other normal sources. In contrast to enzyme obtained from rabbit muscle, the EAC cell enzyme is not significantly inhibited by physiological concentrations of ATP at physiological pH. Kinetic studies using different substrates and inhibitors indicate that the properties of the EAC cell enzyme are significantly different from those of glyceraldehyde-3-phosphate dehydrogenase obtained from other normal sources. The striking dissimilarity of the malignant cell glyceraldehyde-3-phosphate dehydrogenase compared with this enzyme from other normal sources, particularly in respect to the interaction with ATP, may in part explain the high glycolysis of malignant cells.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10336623     DOI: 10.1046/j.1432-1327.1999.00384.x

Source DB:  PubMed          Journal:  Eur J Biochem        ISSN: 0014-2956


  5 in total

Review 1.  Anticancer agents that counteract tumor glycolysis.

Authors:  Carlotta Granchi; Filippo Minutolo
Journal:  ChemMedChem       Date:  2012-06-08       Impact factor: 3.466

Review 2.  CAF cellular glycolysis: linking cancer cells with the microenvironment.

Authors:  Amrita Roy; Soumen Bera
Journal:  Tumour Biol       Date:  2016-04-13

3.  Molecular association of glucose-6-phosphate isomerase and pyruvate kinase M2 with glyceraldehyde-3-phosphate dehydrogenase in cancer cells.

Authors:  Mahua R Das; Arup K Bag; Shekhar Saha; Alok Ghosh; Sumit K Dey; Provas Das; Chitra Mandal; Subhankar Ray; Saikat Chakrabarti; Manju Ray; Siddhartha S Jana
Journal:  BMC Cancer       Date:  2016-02-24       Impact factor: 4.430

4.  The dynamic side of the Warburg effect: glycolytic intermediate storage as buffer for fluctuating glucose and O 2 supply in tumor cells.

Authors:  Johannes H G M van Beek
Journal:  F1000Res       Date:  2018-08-02

5.  Arsenic-based antineoplastic drugs and their mechanisms of action.

Authors:  Stephen John Ralph
Journal:  Met Based Drugs       Date:  2008
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.